Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma

被引：0
|
作者：
Wittlinger, M
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 121
页数：3
相关论文
共 50 条
  • [1] Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Chan, ATC
    Leung, SF
    Ngan, RKC
    Teo, PML
    Lau, WH
    Kwan, WH
    Hui, EP
    Yiu, HY
    Yeo, W
    Cheung, FY
    Yu, KH
    Chiu, KW
    Chan, DT
    Mok, TSK
    Yau, S
    Yuen, KT
    Mo, FKF
    Lai, MMP
    Ma, BBY
    Kam, MKM
    Leung, TWT
    Johnson, PJ
    Choi, PHK
    Zee, BCY
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) : 536 - 539
  • [2] Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma
    Yu, Hong-Sheng
    Wang, Xin
    Song, Ai-Qin
    Liu, Ning
    Zhang, Wei
    Yu, Li
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3961 - 3965
  • [3] Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial
    Chan, ATC
    Teo, PML
    Ngan, RK
    Leung, TW
    Lau, WH
    Zee, B
    Leung, SF
    Cheung, FY
    Yeo, W
    Yiu, HH
    Yu, KH
    Chiu, KW
    Chan, DT
    Mok, T
    Yuen, KT
    Mo, F
    Lai, M
    Kwan, WH
    Choi, P
    Johnson, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 2038 - 2044
  • [4] Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
    Hui, Edwin P.
    Ma, Brigette B.
    Leung, Sing F.
    King, Ann D.
    Mo, Frankie
    Kam, Michael K.
    Yu, Brian K.
    Chiu, Samuel K.
    Kwan, Wing H.
    Ho, Rosalie
    Chan, Iris
    Ahuja, Anil T.
    Zee, Benny C.
    Chan, Anthony T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 242 - 249
  • [5] A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.
    Yamouni, M.
    Beldjilali, Y.
    Benhadji, K. A.
    Khellafi, H.
    Betkaoui, F.
    Kaid, Y.
    Benchlef, L.
    Daim, F. Z.
    Toubal, S.
    Boukerche, A.
    Abdelaoui, A.
    Djellali, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Neoadjuvant docetaxel (Taxotere) and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: a randomized phase II study
    Chan, A. T.
    Hui, E. P.
    Ma, B. B.
    Leung, S. F.
    King, A. D.
    Mo, F.
    Lai, M.
    Yu, K. H.
    Kwan, W. H.
    Zee, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 288 - 288
  • [7] Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
    He, Yan
    Guo, Tao
    Guan, Hui
    Wang, Jingjing
    Sun, Yu
    Peng, Xingchen
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1419 - 1428
  • [8] Efficacy of neoadjuvant docetaxel and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma (NPC): A randomized phase II study
    Hui, E. P.
    Ma, B. B.
    Leung, S. F.
    King, A.
    Mo, F.
    Kam, M. K.
    Yu, K. H.
    Kwan, W. H.
    Zee, B. C.
    Chan, A. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma
    Lei Zhang
    Guo-ping Shan
    Pu Li
    Ping-jing Cheng
    Medical Oncology, 2015, 32
  • [10] The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma
    Zhang, Lei
    Shan, Guo-ping
    Li, Pu
    Cheng, Ping-jing
    MEDICAL ONCOLOGY, 2015, 32 (03)
12345